NEW DELHI: Drug pricing regulator NPPA has asked stent makers and importers to ensure that production as well as supply of stents remains at the level that was there before the introduction of price cap. If there is any non-availability or withdrawal of stents it should inform NPPA immediately," it added. One hospital in the Capital had not put up the revised price list citing non-receipt of the latest prices from company. Stating that it has received complaints about few hospitals refusing to make 'best stents' available on the grounds that companies told them to 'hold' these stents, NPPA said it was a clear violation of DPCO 2013. Clarifying that for the implementation of a price cap, the effective date is the date of billing and not the date of angioplasty.

Source: Economic Times February 22, 2017 11:03 UTC